This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
Commercially available curcumin preparations contain a mixture of related polyphenols, collectively referred to as curcuminoids. These encompass the primary component curcumin along with its co-purified derivatives demethoxycurcumin and bisdemethoxycurcumin. Curcuminoids have numerous biological activities, including inhibition of cancer related cell proliferation and reduction of amyloid plaque formation associated with Alzheimer disease. Unfortunately, the solubility of curcuminoids in aqueous solutions is exceedingly low. This restricts their systemic availability in orally administered formulations and limits their therapeutic potential.
Methods are described that achieve high concentrations of soluble curcuminoids in serum. Solid curcuminoids were either mixed directly with serum, or they were predissolved in dimethyl sulfoxide and added as aliquots to serum. Both methods resulted in high levels of curcuminoid-solubility in mammalian sera from different species. However, adding aliquots of dimethyl sulfoxide-dissolved curcuminoids to serum proved to be more efficient, producing soluble curcuminoid concentrations of at least 3 mM in human serum. The methods also resulted in the differential solubility of individual curcuminoids in serum. The addition of dimethyl sulfoxide-dissolved curcuminoids to serum preferentially solubilized curcumin, whereas adding solid curcuminoids predominantly solubilized bisdemethoxycurcumin. Either method of solubilization was equally effective in inhibiting dose-dependent HeLa cell proliferation in culture. The maximum concentration of curcuminoids achieved in serum was at least 100-fold higher than that required for inhibiting cell proliferation in culture and 1000-fold higher than the concentration that has been reported to prevent amyloid plaque formation associated with Alzheimer disease. Curcuminoids were also highly soluble in solutions of purified albumin, a major component of serum.
These results suggest the possibility of alternative therapeutic approaches by injection or infusion of relatively small amounts of curcuminoid-enriched serum. They also provide tools to reproducibly solubilize curcuminoids for analysis in cell culture applications. The differential solubility of curcuminoids achieved by different methods of solubilization offers convenient alternatives to assess the diverse biological effects contributed by curcumin and its derivatives.
Turmeric is a powder derived from the root of the herb
Curcuminoids possess numerous medicinal properties. These include antiinflammatory, antioxidant, antiviral, antiinfective, antimalarial and wound healing properties [
The antioxidative effect of curcuminoids and their ability to prevent Aβ aggregation has also attracted attention in Alzheimer disease research [
Despite such encouraging reports, the study of curcuminoids is severely limited by their exceedingly low bioavailability following oral administration. This is largely a consequence of their extremely poor solubility and instability in aqueous solutions, in particular at alkaline pH [
BSA [Fraction V, 96–99% albumin], curcuminoids ('curcumin' > 95%) [Fluka], and DMSO [ACS reagent] were obtained from Sigma Chemical Company. 1-butanol (HPLC grade) was purchased from Fisher Scientific. Fetal calf, horse, rat, human and rabbit sera were supplied by Aleken Biologicals. DMEM (high glucose), 0.05% Trypsin-EDTA, and Penicillin-Streptomycin (10,000 units/ml, 100×) were provided by GIBCO (Invitrogen). Acetonitrile and water (both HPLC grade) were obtained from Mallinckrodt Baker Inc. All other standard laboratory chemicals were purchased from Research Organics.
BSA was prepared as 10% or 20% (w/v) stock solutions in PBS (137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl, pH 7.4) and used directly or diluted as indicated. Sera were thoroughly mixed and used as provided. Butanol was equilibrated with an excess of deionized water and used after phase separation. Eluent solutions A (5% acetonitrile, 0.01% ammonium acetate, pH 4.5, and 95% water) and B (95% acetonitrile, 0.01% ammonium acetate, pH 4.5, and 5% water) were used to generate a gradient in reversed phase chromatography (see below).
Either solid curcuminoid powder in varying amounts (1–70 mg) or 10 μl of curcuminoids (10–500 mM) predissolved in DMSO were added to 1 ml of serum or BSA solutions in 1.5 ml microfuge tubes. Solid curcumin was vortexed until the powder was well suspended. When DMSO-dissolved curcuminoids were added to the aqueous protein solution, much of the curcuminoids precipitated and the precipitate was vortexed until suspended. Time course experiments showed that no additional curcuminoid solubilization occurred after 4–6 h of incubation of the suspensions at 4°C. However, to ensure that complete equilibrium was established, incubation was continued on a rotary mixer for 16–24 h. Thereafter, the remaining insoluble curcuminoids were pelleted by centrifugation for 10 min at 14,000 × g. Aliquots of 200 μl were withdrawn for butanol extraction. In all cases, extreme care had to be exercised not to include insoluble curcuminoids in samples designated for butanol extractions, since this would substantially increase the apparent amount of soluble curcuminoids.
For cell culture media preparation, 29 ml of FCS were either mixed with 870 mg (30 mg/ml) of solid curcuminoids or 145 μl (5 μl/ml) of DMSO containing 500 mM curcuminoids. In both cases, the suspended curcuminoids were stirred in 50 ml Erlenmeyer flasks at 4°C for 16–24 h. Residual insoluble curcuminoids were removed by two centrifugations at 14,000 × g. From the resulting FCS-curcuminoid solution, 1 ml was collected for butanol extraction and spectrophotometric concentration determination, or reversed phase chromatography. Of the remaining FCS-curcuminoid solution, 25 ml were added to 500 ml of DMEM. The resulting media were sterilized through 0.45 μm filters (Pall Life Sciences). Aliquots of 0.5 ml were then removed for butanol extraction and concentration determination. Curcuminoid-containing media were diluted with standard medium to obtain the desired final curcuminoid concentrations.
In experiments addressing the influence of mixing technique on curcuminoid solubility, solid curcuminoids were added to 10 ml of FCS (30 mg/ml) and mixed either by magnetic stirring at medium speed in a 25 ml Erlenmeyer flask, or by rotation on a rotational mixer for 16–24 h. Alternatively, DMSO-dissolved curcuminoids (500 mM) were added to 10 ml of FCS (5 μl/ml) and similarly mixed.
A spectral scan was generated with a 6 μM solution of curcuminoids in water-saturated butanol, which was obtained by diluting a 500 mM stock solution of curcuminoids dissolved in DMSO. The background absorption scan was derived from water-saturated butanol without curcuminoids. Aliquots of 200 μl were placed in a 96-well microplate and scanned at 1 nm increments between wavelengths of 370 and 460 nm in a μ Quant microplate spectrophotometer (Bio-Tek Instruments) [Fig.
Curcuminoids were extracted from 200 μl serum or BSA solutions by mixing with 1 ml of water-saturated butanol. Water-saturated butanol was used instead of pure butanol because water partitions into the butanol phase at a volume ratio of slightly more then 1/10. The biphasic solution was thoroughly vortexed and phases were separated by microcentrifugation. Aliquots of 200 μl of the upper butanol phase were removed and either added directly to a 96-well microplate (Corning Inc.) or further diluted with butanol at ratios of 1:5 or 1:10 to achieve OD values within the linear absorption range. The background OD readings were uniformly about 0.1 (+/- 0.01) OD units and these values were subtracted from those obtained with the extracted curcuminoid solutions. Because of the lower concentration of curcuminoids in cell culture media, aliquots of 0.5 ml were extracted with 1 ml of butanol. In both cases, more than 95% of the curcuminoids uniformly partitioned into the organic phase. However, DMEM and other tissue culture media typically contain the indicator dye Phenol Red, which also partially partitions into the butanol phase. This resulted in higher background readings of about 0.220 OD (+/- 0.02) units. These higher background readings that in these instances were subtracted from the experimental values did not appreciably affect measurement accuracy or precision.
HeLa cells (ATCC#: CCL-2) were grown in DMEM containing 5% FCS and penicillin-streptomycin (100 units/ml) at 37°C in an incubator equilibrated with 5% CO2. For cell survival analysis, cells were seeded at about 20% confluence in 25 cm2 flasks (Sarstedt). Cells were photographed in three random viewing fields using phase contrast microscopy (Minolta) and counted. The number obtained from the initial cell count was designated as 100%. Thereafter, cells were incubated in media containing 0, 10, 20, 30, 40, and 50 μM soluble curcumin. Media were changed and cells counted daily during three days of incubation.
The stability of soluble curcuminoids in cell culture media stored at 4°C was measured by extracting 0.5 ml aliquots of media with 1 ml of butanol at indicated time intervals between 0 and 28 days after preparation. Alternatively, 10 ml of media were stored in 25 cm2 flasks at 37°C in a tissue culture incubator, either with or without CO2 exposure. Aliquots of 0.5 ml were removed for curcuminoid extractions at intervals ranging from 0 to 9 days. Background measurements were subtracted from identically incubated media devoid of curcuminoids.
Either 36 mg of solid curcuminoids or 12 μl of 500 mM DMSO-dissolved curcuminoids were added to 1.2 ml of 5% BSA or FCS and processed as described. Thereafter, the insoluble curcuminoids were pelleted by centrifugation and the entire supernatant removed. Aliquots of 200 μl were butanol extracted for total curcuminoid determination and 20 μl were extracted for reversed phase chromatography. The remaining supernatants were mixed with either 30 mg of solid curcuminoids or 10 μl of 500 mM DMSO-dissolved curcuminoids in reverse order. The suspensions were reincubated and then processed for concentration determination.
Solid curcuminoids in amounts of 1, 10, 20, 30, 40, and 50 mg were added to 1 ml of 5% BSA and incubated as described above. Thereafter, the insoluble curcuminoids were pelleted by centrifugation and the entire supernatant removed, followed by adding 1 ml of fresh 5% BSA to the remaining pellet. Aliquots of 200 μl were extracted with 1 ml of butanol and the concentration of total soluble curcuminoids was determined. Where applicable, 20 μl aliquots were analyzed by reversed phase chromatography. This process was repeated 10 times. After the last extraction, the remaining insoluble curcuminoid pellets were washed three times with deionized water and dried under vacuum. The dried pellets were then dissolved in 200 μl DMSO. Aliquots were diluted in butanol and the yield of curcuminoids in the final pellet determined spectrophotometrically. Aliquots of 10 μl from the respective DMSO-dissolved final pellets were then added to 1 ml of 5% BSA and solubilized as described above for concentration determination and reversed phase chromatography.
Curcuminoids solubilized in protein solutions (20 μl) or media samples (200 μl) were extracted for reversed phase chromatography with 300 μl of water-saturated butanol and evaporated in a Savant Speed-Vac concentrator attached to a vacuum pump. The dried residue was reconstituted in a 0.5 ml solution containing 75% eluent A (5% acetonitrile, 0.01% ammonium acetate, pH 4.5, and 95% water) and 25% eluent B (95% acetonitrile, 0.01% ammonium acetate, pH 4.5, and 5% water), representing an acetonitrile concentration of 27.5%. Reversed phase chromatography was performed on an FPLC Äkta Purifier system equipped with a Source 5RPC ST 4.6/150 column (GE Healthcare). Reconstituted curcuminoids (300–400 μl) were loaded onto a 100 μl sample loading loop and separated with a 35 ml linear gradient, which ranged from a starting concentration of 75% eluent A and 25% eluent B to a final concentration of 15% eluent A and 85% eluent B (27.5% – 81.5% acetonitrile) at a flow rate of 1 ml/min. The eluent was monitored at a wavelength of 427 nm. Quantitation of individual peaks was carried out with the Unicorn (version 2.2) peak integration program.
The arithmetic mean of the molecular masses of the three curcuminoids (338 kDa) was used as a general reference value for spectrophotometric concentration calculations. This was necessary since the relative contribution of each curcuminoid varied considerably between different experimental conditions. In addition, the molar absorptivity (ε) of the three curcuminoids dissolved in ethanol were shown to vary from 6.73 (x104 L cm-1mol-1) for curcumin to 4.95 for bisdemethoxycurcumin at 425 nm [
All data points were calculated as the average of at least three independent experiments, each assayed in duplicate. Error bars represent the standard deviation from the average. Where applicable, the concentration of soluble curcumin as a function of added curcumin was fitted to an exponential saturation function with Sigma Plot software.
Spectrophotometry was used to systematically determine the concentration of soluble total curcuminoids in serum. Since this required a reliable dose curve, it was essential to solvent-extract the solubilized curcuminoids from the aqueous solutions in a quantitative manner. An ideal solvent proved to be water-saturated butanol, which has the capacity to solubilize curcuminoids up to an approximately 9.5 mM concentration. This solvent is relatively nontoxic and it has a low vapor pressure, which eliminates concerns about volume changes due to evaporation during the assay. It is also chemically inert to the polystyrene used in microplates. After the first extraction of 200 μl FCS-solubilized curcuminoids with 1 ml of butanol, more than 95% of the soluble curcuminoids partitioned into the butanol phase.
A spectral scan between wavelengths 370 nm and 460 nm produced a maximum absorption plateau between wavelengths 425 nm and 431 nm (Fig.
A 50 μM solution of Curcuminoids in butanol was further analyzed by reversed phase chromatography. Three sequential peaks were eluted that were identified as curcumin (retention time (rt): 26 min), demethoxycurcumin (rt: 24.8 min), and bisdemethoxycurcumin (rt: 23.6 min) [Fig.
Using these spectrophotometric parameters, a systematic analysis of the solubility of curcuminoids in FCS was carried out (Fig.
To determine whether adding a defined concentration of curcuminoids predissolved in an organic solvent would alter the final solubility in FCS, 10 μl of DMSO-dissolved curcuminoids at concentrations ranging from 20 mM to 500 mM were added to 1 ml of FCS (Fig.
Since albumin is a major component of total serum protein, the solubility of curcuminoids in BSA solutions was also examined. BSA was dissolved in phosphate-buffered saline (PBS) at a concentration of 5%. One milliliter of this solution was then incubated with solid curcuminoids in amounts ranging from 1–70 mg (Fig.
When the constant amount of 30 mg solid curcuminoids was added to 1 ml of solutions with increasing concentrations of BSA (0.2–10%), saturation was observed at about 5% BSA yielding a soluble curcuminoid concentration of about 1200 μM, which again represented a molar curcuminoid/BSA ratio of 1.6 (Fig.
In contrast, when 10 μl of DMSO-dissolved curcuminoids at a constant 500 mM concentration were added to solutions with increasing concentrations of BSA, the BSA-soluble curcuminoid concentration increased to a maximum of about 4500 μM, which was obtained at BSA concentrations above 14% (Fig.
At saturating BSA concentrations (14–20%), the amount of DMSO-dissolved curcuminoids converted into BSA-solubilized curcuminoids was about 92–96% (Fig.
The differential solubility of curcuminoids in FCS and BSA solutions was also analyzed by reversed phase chromatography (Fig
This differential solubility of the curcuminoids was further investigated by sequentially incubating 5% BSA or FCS with either 30 mg of solid curcuminoids or with 10 μl of 500 mM DMSO-dissolved curcuminoids. When 5% BSA or FCS was first incubated with solid curcuminoids followed by incubation with DMSO-dissolved curcuminoids, a several-fold increase in the concentration of BSA- and FCS-solubilized curcuminoids was achieved (Fig.
The sequentially solubilized curcuminoids in FCS and 5% BSA were also analyzed by reversed phase chromatography. The elution profiles showed a similar pattern for both 5% BSA and FCS (Fig.
In contrast, when the protein solutions were first incubated with solid curcuminoids followed by DMSO-dissolved curcuminoids the elution profile changed dramatically. The relative levels of bisdemethoxycurcumin and demethoxycurcumin were essentially the cumulative sum of the individually added solid and DMSO dissolved curcuminoids in both FCS and 5% BSA. However, the relative solubility of curcumin following sequential addition was only consistent with the sum of the individual additions to FCS (Fig.
These results affirm that the mechanisms for converting solid and DMSO-dissolved curcuminoids into BSA- and FCS-soluble curcuminoids are profoundly different. The reason for these differences is uncertain, in particular since a major portion of the DMSO-dissolved curcuminoids initially precipitate upon addition to the aqueous protein solution. It is conceivable that this is due to differences in structure between the added solid curcuminoids and the curcuminoids precipitated from the DMSO solution. Commercial curcuminoids are commonly produced by the extraction of turmeric powder with a range of organic solvents followed by evaporation [
The differential solubility of curcuminoids was further examined by adding solid curcuminoids in amounts of 10, 20, 30, 40, and 50 mg to 5% BSA (Fig.
After the final tenth incubation, the remaining solid curcuminoid pellet was rinsed three times in water and dried under vacuum. The dried curcuminoids were dissolved in 200 μl DMSO and the concentration determined spectrophotometrically after serial dilution of aliquots in butanol. The total amount of curcuminoids in the remaining pellets had declined by only 3–17% following ten incubations with fresh 5% BSA (Fig.
Sequential extraction of 1 and 50 mg of curcuminoids with 5% BSA was also monitored by reversed phase chromatography (Fig.
Following the repeated extraction of the larger amount of curcuminoids (50 mg), a different pattern emerged. While the relative level of bisdemethoxycurcumin declined over ten extractions, the relative amount of demethoxycurcumin increased after five extractions and remained constant thereafter. Compared to the extraction of 1 mg curcuminoids, the extraction of 50 mg resulted in a much lower increase in the relative amount of soluble curcumin. There was also less depletion of bisdemethoxycurcumin and demethoxycurcumin in the final pellet (Fig.
These results again confirm that the three curcuminoids exist in the preparation of solid curcuminoids in different solid forms, such that each curcuminoid is differentially available for solubilization in 5% BSA. The repeated extractions of either 1 mg or 50 mg of solid curcuminoids show that the bisdemethoxycurcumin was most readily available for solubilization, followed by demethoxycurcumin. When these respective sources were depleted, curcumin was available for limited solubilization, while the total amount of curcuminoids available for solubilization was declining. Nevertheless, even after 10 extractions the depletion of bisdemethoxycurcumin and demethoxycurcumin was not complete, since residual amounts remained in the final curcuminoid pellets.
It is conceivable that the curcuminoids exist as a mixture of pure and mixed crystals in the commercial preparations of solid curcuminoids. Since curcumin is the most prevalent curcuminoid in the mixture, this compound would be more likely to form pure crystals. It is tempting to speculate that mixed crystals are easier to solubilize than pure crystals, resulting in the preferential solubilization of bisdemethoxycurcumin and demethoxycurcumin from the crystalline state. The notion that crystal structure is a possible parameter in the solubility properties of solid curcumin is supported by the following observation. Solid curcumin (30 mg) was dissolved in 1 ml of acetone and allowed to completely evaporate at room temperature. The residual curcuminoids were then incubated with 5% BSA and the solubilized curcuminoids analyzed by reversed phase chromatography. The elution profile of curcuminoids solubilized from this solid (B: 23%, D: 33%, C: 44%) differed profoundly from that obtained from the original commercial preparation (B: 74%, D: 26%, C: 3%) [Fig
These results also suggest that BSA may form complexes with curcuminoids that differ in their binding affinities. For example, when DMSO-dissolved curcuminoids are first solubilized in 5% BSA, all high and most of the low affinity binding sites would be occupied. Consequently, upon further incubation with solid curcuminoids no additional solubilization would occur, since all available sites would already be occupied. In contrast, when 5% BSA is first incubated with solid curcuminoids, only the high affinity binding sites would be accessible for limited solubilization. The remaining lower affinity sites would then be available for subsequent solubilization of DMSO-dissolved curcuminoids, resulting in an additive response (Fig.
Although albumin is a major mediator of curcuminoid solubility in serum, it is likely that other components also contribute. A comparison of sera from different mammalian species showed a high degree of variation both in total protein and albumin contents as well as their ability to solubilize curcuminoids. The highest level of curcuminoid solubility was observed in human serum followed by horse, rabbit, rat and fetal calf serum (Fig.
The effect of freeze-thawing sera on curcuminoid solubility was not systematically examined here. However, throughout the study, both FCS and BSA solutions were frozen and thawed multiple times without apparent effect on their ability to solubilize curcuminoids. Similarly, serum already containing soluble curcuminoids could be frozen and thawed without evidence of further curcuminoid precipitation or decline in biological activity.
Curcuminoids were solubilized in FCS for use in tissue culture medium to explore their effect on biological activity. Specifically, 29 ml of FCS were mixed either with 870 mg of solid or 145 μl of 500 mM DMSO-dissolved curcuminoids for 16–24 h with a magnetic stirrer. The final concentration of soluble curcuminoids was 966 μM for the preparation with solid curcuminoids and 850 μM for the preparation with DMSO-dissolved curcuminoids (Fig.
Unexpectedly, the curcuminoid concentration achieved by stirring solid curcuminoids was about twice as high as that anticipated from the results described in Fig.
Reversed phase chromatography of the DMSO-dissolved curcuminoids solubilized in FCS by the two mixing methods revealed no differences in the levels of individual curcuminoids (Fig
This demonstrates that particle size, resulting from different mixing methods is an important parameter in determining the relative solubility of individual and total curcuminoids. The effect of reducing particle size is particularly relevant when solubilizing solid curcumin. It is possible that other mixing methods not examined here, such as extended vortexing, could produce additional patterns of curcuminoid solubilization profiles. These results suggest additional parameters for differentially enriching specific curcuminoids in serum and cell culture media.
The stability of curcuminoids was investigated in cell culture media. Media prepared with solid and DMSO-dissolved curcuminoids were about equally stable when stored in a refrigerator at 4°C, both declining to about 70% of the original value during a four-week period (Fig.
The declining stability of curcumin in solution was defined as the loss of absorption at the wavelength of 427 nm. Curcumin was found to rapidly decompose in aqueous solutions, yielding the final degradation products vanillin, ferulic acid, and feruloyl methane [
These conclusions were supported by reversed phase chromatography of curcuminoids from media incubated at 37°C in the presence of 5% CO2. In media containing serum prepared with stirred solid curcuminoids, the starting profile was the same as that shown in Fig.
In media containing serum prepared with DMSO-dissolved curcuminoids, the starting concentration of the individual curcuminoids (Fig.
Media containing serum prepared with either solid or DMSO-dissolved curcuminoids were compared for their effect on cell growth and survival. The freshly prepared media were diluted with curcuminoid-free medium to 0, 10, 20, 30, 40, or 50 μM concentrations of curcuminoids. HeLa cells were seeded at a density of about 20% confluence (designated as a relative starting cell number of 100%) and then incubated at these curcuminoid concentrations for three days. The results were indistinguishable for media prepared either with solid curcuminoids or with DMSO-dissolved curcuminoids (Fig.
In other reported cell culture studies, curcumin inhibited cell growth or induced apoptosis in a variety of cell lines at concentrations ranging from 10–100 μM [
Methods are described that enable the solubilization of curcuminoids at high concentrations in serum or albumin solutions. The serum-solubilized curcuminoids can be quantitatively extracted with water-saturated butanol and their concentration determined spectrophotometrically at 427 nm. Once curcuminoids are dissolved, the serum can be diluted or concentrated at will without evidence of precipitation (data not shown). This allows for the preparation of cell culture media with precisely defined curcuminoid concentrations. The concentration of total curcuminoids that can be achieved in serum is about 100-fold higher than that required for inhibition of cell proliferation activity in cell culture systems [
In addition to providing generally high concentrations of soluble curcuminoids, the described procedures offer the opportunity to adjust the level of individual curcuminoids in serum preparations. For example, if solid curcumin is used to prepare serum, the predominant solubilized curcuminoid is bisdemethoxycurcumin, whereas curcumin predominates when DMSO-dissolved curcuminoids are used. Variations in mixing techniques for solubilizing solid curcuminoids in serum offer additional alternatives for maximizing solubility and modifying curcuminoid ratios. Furthermore, curcuminoids solubilized in sera by different methods can be combined to achieve optimal curcuminoid ratios for specific treatment regiments or cell culture applications.
FCS: fetal calf serum; BSA: bovine serum albumin; PBS: phosphate-buffered saline; DMSO: dimethylsulfoxide; APP: amyloid precursor protein; DMEM: Dulbecco's Modified Eagle Medium; OD: optical density; ATCC: American Type Culture Collection; PVP: polyvinylpyrrolidine; rt: retention time; mAU: milliabsorption units.
This work was supported by National Institutes of Health Grant NS30994.